Project Grant H79TI088314
- This Project Grant award for $697,500 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will fund the "HEPC FREE: CORRIDOR OF CARE" initiative led by US Helping Us-People Into Living, Inc. The 3-year project aims to eliminate hepatitis C (HCV) among unsheltered individuals and those with substance use disorders, serious mental illness, or...
- This federal Project Grant award, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, provides $1,000,000 to implement a Hepatitis C Virus (HCV) treatment program focused on achieving high cure rates among homeless individuals with serious mental illness and/or substance use disorders. The key goals of the project are to: 1) Cure at least 65...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $2,092,500 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Odyssey House Louisiana, Inc. The grant will fund the implementation of a comprehensive Hepatitis C elimination program to serve high-risk individuals, including those experiencing homelessness, substance use disorder, and mental illness. Key elements of the program...
- This federal Project Grant award of $999,998.00 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant recipient, Brandywine Counseling & Community Services, Inc. (BCCS), will implement the "HEP C FREE DELAWARE" pilot project to deliver statewide, low-threshold care integrating rapid hepatitis C virus (HCV) testing,...
- This $3,907,500 federal Project Grant award was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant, awarded to Meharry Medical College, aims to eliminate hepatitis C (HCV) among high-risk populations including people who use drugs, individuals experiencing homelessness, and those with co-occurring mental illness in Nashville/Davidson...
- This Project Grant award of $3,907,500 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will fund the "HEP C FREE PUERTO RICO INTEGRATED CARE PILOT" delivered by Mennonite General Hospital, Inc. (MGHPR). The project aims to screen 10,000 high-risk adults, initiate direct-acting antiviral (DAA) therapy in 1,150, and confirm cure (SVR12)...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $3,907,500 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Tarrant County Hospital District, doing business as JPS Health Network, in Fort Worth, Texas. The "Prevention, Access, Treatment and Healing (PATH)" program aims to eliminate hepatitis C virus (HCV) among medically underserved and high-risk populations in...
- This federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will provide $2,605,000 to Bienestar Human Services, Inc., a non-profit organization based in Los Angeles, California. The award will fund an initiative to deliver same-day hepatitis C virus (HCV) testing and treatment, integrated behavioral health care, and peer-led...
- This $4,450,466.00 Formula Grant was awarded on August 1, 2024 by the Substance Abuse and Mental Health Services Administration (SAMHSA) within the U.S. Department of Health and Human Services. The grant is part of the Projects for Assistance in Transition from Homelessness (PATH) program (CFDA 93.150), which provides funding to state and territorial agencies to deliver comprehensive services for individuals experiencing serious mental illness, co-occurring substance abuse disorders, and...
- The University of Florida (UF), through its Division of Sponsored Research, was awarded a $349,955 Project Grant from the U.S. Department of Agriculture's National Institute of Food and Agriculture's Rural Health and Safety Education (RHSE) Competitive Grants Program (CFDA 10.516). This 3-year project, starting on September 1, 2023, will support the implementation of a multilevel, multi-sector, community-based educational program with the overall goal of improving chronic disease self-management...
The University of Florida (UF) was awarded a $1,349,445 Project Grant from the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program administered by the U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA). The CURE-HCV program aims to eliminate hepatitis C among populations facing significant health challenges, including homelessness, substance use disorder, and serious mental illness, in North Central Florida and Jacksonville. Over 3 years, the program will provide same-day hepatitis C and rapid HIV testing, along with immediate hepatitis C treatment initiation, to an estimated 180-225 individuals, the majority of whom are experiencing homelessness and uninsured. The program will leverage UF's mobile outreach clinic, emergency department, and recovery center, partnering with community organizations to reach and support this vulnerable population. The grant award period runs from September 30, 2025 to September 29, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.3m | 9/24/25 |